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ABSTRACT
Objectives: This study was performed to evaluate the relationship between obstructive sleep apnea syndrome and preg-
nancy complications.
Material and methods: A total of 500 women (18–45 years) who had delivered (vaginal delivery or caesarean section) 
between January 2017 and March 2017 in our clinic were included in the study. Patients at high risk for obstructive sleep 
apnea syndrome were identified using the Stop Bang questionnaire. Based on the results of the questionnaire, pregnancy 
complications were compared between high-risk pregnant women (Group 1) and low-risk pregnant women (Group 2).
Results: Age, body mass index, smoking rate, and the rate of systemic disease (e.g., diabetes and/or hypertension) were 
higher in Group 1 than in Group 2 (p < 0.05). Rates of preeclampsia, gestational diabetes, preterm labor, premature rupture 
of the membranes, and cesarean section were significantly higher in Group 1 than in Group 2 (p < 0.05).
Conclusions: Obstructive sleep apnea syndrome is associated with a higher rate of maternal complications among pregnant 
women. Affected patients should be carefully monitored.
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INTRODUCTION
Sleep is a fundamental daily need, and a lack of sleep 
could negatively influence quality of life. The need for sleep 
changes occasionally because of various hormonal, environ-
mental, and psychological changes. Through various physi-
ological and hormonal mechanisms, pregnancy can create 
substantial changes in respiratory function during sleep. 
These changes cause large differences in sleep quality and 
pattern during pregnancy [1]. The frequency of respiratory 
disorders, from simple snoring to severe obstructive sleep 
apnea syndrome (OSAS), has been reported to increase in 
pregnant women [2]. Narrowing of the oropharynx, nasal 
congestion caused by increased blood flow and estrogen, 
and hyperventilation are known to increase susceptibility 
to OSAS during pregnancy [3, 4]. Other contributing factors 
include progressive weight gain and upward displacement 
of the diaphragm. OSAS is a respiratory disorder character-
ized by upper airway obstruction and hypoxemia during 
sleep; it is experienced by 2% of women in the general popu-
lation [2]. The rates of premature birth, cesarean section, 
preeclampsia, low birth weight, and gestational diabetes 
are higher in pregnant women at high risk for OSAS than in 
pregnant women without OSAS [5–10]. The aim of this study 
was to investigate the relationships between pregnancies 
at high risk of OSAS and pregnancy complications, mode of 
delivery, and delivery week.
MATERIAL AND METHODS
Study design and population
This study included 500 patients (age range, 18–
45 years) who agreed to participate in the study and had 
delivered (vaginal delivery or caesarean section) between 
January 2017 and March 2017 at Bursa Training and Research 
Hospital/University of Health Sciences. The study protocol 
was approved by the ethics committee of the university 
(2011-KAEK-25). Informed consent was obtained from all 
participants. Patients were included if they gave birth in our 
hospital to a live baby and were not of foreign nationality. 
Patients were excluded if they were adolescents and/or had 
delivered at another hospital. 
Age, number of pregnancies, body mass index (BMI), 
chronic disease status, drug use status, smoking status, 
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obstetric history, routine pregnancy test results, delivery 
mode, gestational week, baby weight, and baby sex were 
recorded for all 500 patients. The pregnancy complications 
(e.g., hypertensive diseases of pregnancy, preeclampsia, 
preterm birth, gestational diabetes, fetal growth restric-
tion, oligohydramnios, and polyhydramnios) and neonatal 
information (e.g., neonatal weight, sex, low birth weight, and 
large infant size) were recorded for all participants.
Study procedures
The Turkish version of the Stop Bang questionnaire 
— the most used questionnaire in obstetrics — was used 
to evaluate sleep apnea and sleepiness [11]. The Stop Bang 
questionnaire consists of eight questions and has been 
used for community screening of OSAS. Patients with two 
or more positive answers to the first four questions, or three 
or more positive answers to all eight questions, were con-
sidered to be at high risk for OSAS. Based on the question-
naire results, the pregnant women were divided into two 
groups: high-risk pregnancy (Group 1) and low-risk preg-
nancy (Group 2). The two groups were compared in terms 
of demographic characteristics, medical findings, pregnancy 
complications, and newborn information. The Stop Bang 
questionnaire was administered to hospitalized patients 
at 24 hours after birth. The questionnaires were completed 
in face-to-face interviews. The answers were marked on the 
questionnaire form. The completed questionnaire forms 
were collected for statistical analysis.
Statistical analysis
PASW Statistics, version 18.0 (SPSS Inc., Chicago, IL, USA) 
was used for statistical analysis. The chi-squared test and 
t-test were used for statistical comparisons. Categorical 
variables are presented as numbers and percentages, while 
continuous variables are presented as means ± standard 
deviations. Differences with p < 0.05 were considered sta-
tistically significant.
RESULTS
The questionnaire was administered to all patients 
in this study. Seventy-three (14.6%) patients were in 
Group 1 and 427 patients (85.4%) were in Group 2. The 
mean age of all patients was 28.0 ± 5.7 years. Mean BMI 
was 29.0 ± 4.4 kg/m2 and the nulliparity rate was 23.2% 
(116 patients). Age, BMI, and the rates of smoking, chronic 
hypertension, and pregestational diabetes were higher in 
Group 1 than in Group 2 (p < 0.05) (Tab. 1).
The rates of preeclampsia, gestational diabetes, preterm 
birth, premature preterm birth, premature rupture of the 
membranes, and macrosomia were higher in Group 1 than in 
Group 2, whereas fetal growth restriction, oligohydram-
nios, and intrauterine exitus rates were similar between the 
groups (Tab. 1). The cesarean section rate was significantly 
higher in Group 1 than in Group 2 (75.3% vs 43.3%; p < 0.001). 
DISCUSSION
In our study, 500 women who had given birth were 
evaluated and 73 women (14.6% of the participants) were 
at high risk for OSAS. The frequency of OSAS is reportedly 
2–26% in the general population worldwide, although it 
varies among communities [12, 13]. The prevalence of OSAS 
during pregnancy differs with respect to patient ethnicities 
and diagnostic tests used, but is reportedly 20–35%, particu-
larly in patients with high-risk pregnancies [14, 15]. In our 
study, the prevalence of OSAS was less frequent than has 
been described in the literature. This discrepancy is poten-
tially related to differences in populations and ethnicities; 
notably, our study included high-risk pregnant women and 
pregnant women from the entire population. The prevalence 
of OSAS in pregnant women (low-risk pregnant women) in 
Turkey is 11.4–12.5% [16, 17].
In our study, BMI was higher in pregnant women with 
OSAS than in pregnant women without OSAS. Thus, high BMI 
was closely related to OSAS in pregnant women. It has been 
reported that excess weight and obesity before and during 
pregnancy are strongly associated with the development 
Table 1. Comparisons of demographic characteristics between patients with and without obstructive sleep apnea syndrome (OSAS)
Demographic characteristics Group 1 (OSAS +)(n = 73)
Group 2 (OSAS -)
(n = 427) p value
Age* 29.7 ± 5.3 27.7 ± 5.7 0.004
Nulliparity** 12 (16.4) 104 (24.4) 0.139
Smoking** 11 (15.1) 32 (7.5) 0.033
BMI* 34.4 ± 5.2 28.1 ± 3.5  < 0.001
Pre-GDM** 8 (11) 7 (7.6)  < 0.001
Chronic HT** 5 (6.8) 3 (0.7)  < 0.001
Hypothyroidism** 4 (5.5) 25 (5.9) 0.899
BMI — body mass index; Pre-GDM — pregestational diabetes mellitus; HT — hypertension; data are shown as mean ± standard deviation* and n (%)**
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of OSAS during pregnancy. [17, 18]. In addition, while OSAS 
was 3.69-fold higher in overweight pregnant women (BMI: 
25–29.9 kg/m2) than in normal-weight pregnant women, it 
was 13.23-fold higher in obese (BMI ≥ 30.0 kg/m2) pregnant 
women [18]. In our study, mean BMIs were 34.4 ± 5.2 kg/m2 in 
pregnant women with OSAS and 28.1 ± 3.5 kg/m2 in preg-
nant women without OSAS.
In our study, the smoking rates were 15.1% in pregnant 
women with OSAS and 7.5% in pregnant women without 
OSAS. In a study that evaluated the relationship between 
OSAS and smoking during pregnancy, smoking caused 
a 3.39-fold increase in sleep-related problems [19]. OSAS 
was twice as frequent in pregnant women who smoked.
Untreated OSAS contributes to many systemic diseas-
es, such as systemic hypertension, myocardial infarction, 
and neuropsychiatric sequelae [20–22]. In our study, the 
prevalence rates of pregestational diabetes and chronic 
hypertension were higher in pregnant women with OSAS 
than in those without OSAS. Hypertension and diabetes 
are reportedly strongly associated with OSAS in the general 
population [23–26]. The relationships between OSAS and 
both hypertension and diabetes may be related the asso-
ciations of these diseases with obesity, which is associated 
with OSAS. In particular, hypertension is an independent 
risk factor in patients with OSAS [23]. Relationships between 
OSAS and both gestational diabetes and hypertensive dis-
eases of pregnancy have been reported; however, there are 
insufficient data in the literature regarding the relationship 
between pregestational diabetes and chronic hypertension. 
A relationship has been reported between preeclampsia 
and OSAS [27]. However, some studies have shown that 
preeclampsia is not associated with OSAS [8]. In a me-
ta-analysis, Chen et al. [7] found that the relative risk of 
preeclampsia for OSAS was 1.60 (95% CI, 2.16–11.26). In our 
study, the rate of preeclampsia was significantly higher in 
pregnant women with OSAS than in those without OSAS. 
Furthermore, the frequency of chronic hypertension was 
approximately two-fold higher in pregnant women with 
OSAS than in those without OSAS [27]. In our study, the rate 
of chronic hypertension was higher in pregnant women with 
OSAS than in those without OSAS.
Gestational diabetes is also strongly associated with 
OSAS during pregnancy. Gestational diabetes is 6.6-fold 
more common in pregnant women with OSAS than in those 
without OSAS [10]. Şahin et al. [17] reported that the risk of 
OSAS increases by 7.7-fold in pregnant women with gesta-
tional diabetes. However, some other studies have shown 
conflicting results [8, 28]. In our study, the prevalence of 
gestational diabetes was significantly higher in pregnant 
women with OSAS than in those without OSAS. Further stud-
ies and meta-analyses are needed to clarify this discrepancy.
In our study, both early (< 34 weeks) and late (< 37 weeks) 
preterm delivery prevalence rates were higher in pregnant 
women with OSAS than in those without OSAS. The preva-
lence of preterm birth is generally higher in women with 
OSAS than in those without OSAS [5, 9, 27]. The most im-
portant factor associated with the high preterm birth rate 
in pregnant women with OSAS is the high prevalence of 
perinatal complications; moreover, there is a strong relation-
ship between OSAS and iatrogenic preterm birth rates (e.g., 
preeclampsia and fetal growth restriction) [27]. Our results 
showed that the preterm birth rate was higher in pregnant 
women with OSAS; in contrast, spontaneous and indicated 
preterm delivery rates did not differ from those of pregnant 
women without OSAS. However, both preeclampsia and ear-
ly membrane rupture rates were higher in pregnant women 
with OSAS than in those without. Thus, preterm deliveries 
were encountered due to spontaneous premature rupture 
of the membranes, in addition to indicated preterm births.
The limitations of this study were as follows. First, the 
study assessed OSAS by questionnaire, rather than polysom-
nography. Second, the study did not involve follow-up re-
Table 2. Comparisons of pregnancy-related complications between patients with and without obstructive sleep apnea syndrome (OSAS)
Pregnancy Complications Group 1 (OSAS +)(n = 73)
Group 2 (OSAS -)
(n = 427) p value
Preeclampsia 13 (17.8) 12 (2.8)  < 0.001
GDM 9 (12.3) 14 (3.3)  < 0.001
Preterm Birth (< 37 weeks) 21 (28.8) 45 (10.5)  < 0.001
Preterm Birth (< 34 weeks) 12 (16.4) 22 (5.2)  < 0.001
Macrosomia 7 (9.6) 6 (1.4)  < 0.001
PROM 6 (8.2) 11 (2.6) 0.014
FGR 6 (8.2) 25 (5.9) 0.439
Oligohydramnios 9 (12.3) 29 (6.8) 0.099
Intrauterine Fetal Death 1 (1.4) 4 (0.9) 0.731
GDM — gestational diabetes mellitus; FGR — fetal growth restriction; PROM — premature rupture of the membranes; data are shown as n (%)
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garding the neonatal findings and did not include pre-preg-
nancy weight and BMI data. However, this study had mul-
tiple strengths, including the large number of patients and 
prospective study design. To the best of our knowledge, this 
is the first study involving screening of the general pregnant 
population in Turkey for characteristics of OSAS.
CONCLUSIONS
The results showed that complications such as preec-
lampsia, gestational diabetes, preterm labor, and rupture of 
the membranes were more common in pregnant women 
with OSAS than in healthy pregnant women. Appropriate 
evaluations should be administered to pregnant women 
with symptoms of OSAS during the antenatal follow-up; 
pregnant women with OSAS should be closely monitored 
for possible pregnancy-related complications. 
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